InvestorsHub Logo
Followers 14
Posts 306
Boards Moderated 0
Alias Born 01/17/2021

Re: Number sleven post# 367512

Tuesday, 01/25/2022 7:14:34 PM

Tuesday, January 25, 2022 7:14:34 PM

Post# of 426478
NS - just that the COVID case analyses ...

... will be just a subset of the overall viral pathogen patients. It may be the non-COVID respiratory virus patients that show the greatest improvement from Vascepa.

It is an interesting presentation title. Do you read anything into it?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News